SMC1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.270400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.046600E-01
Normal-vs-Stage2
2.426400E-01
Normal-vs-Stage3
9.065500E-02
Normal-vs-Stage4
9.682000E-01
Stage1-vs-Stage2
6.655400E-01
Stage1-vs-Stage3
1.202380E-01
Stage1-vs-Stage4
5.748000E-01
Stage2-vs-Stage3
1.536630E-01
Stage2-vs-Stage4
2.156400E-01
Stage3-vs-Stage4
1.567360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.876760E-01
Normal-vs-AfricanAmerican
8.565400E-01
Normal-vs-Asian
2.154600E-01
Caucasian-vs-AfricanAmerican
2.460300E-02
Caucasian-vs-Asian
6.024600E-01
AfricanAmerican-vs-Asian
8.478000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.854100E-02
Normal-vs-Female
6.186000E-01
Male-vs-Female
4.98059999998191E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.634400E-01
Normal-vs-Age(41-60Yrs)
5.867200E-01
Normal-vs-Age(61-80Yrs)
1.236770E-01
Normal-vs-Age(81-100Yrs)
1.390010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.653000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.623200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.524400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.116600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.041390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.925700E-02
Normal-vs-Daily Drinker
1.686030E-01
Normal-vs-Weekly Drinker
2.791400E-01
Normal-vs-Occasional Drinker
4.475000E-01
Normal-vs-Social Drinker
5.718200E-01
Non Drinker-vs-Daily Drinker
9.761600E-01
Non Drinker-vs-Weekly Drinker
5.596200E-01
Non Drinker-vs-Occasional Drinker
1.253800E-01
Non Drinker-vs-Social Drinker
7.078400E-02
Daily Drinker-vs-Weekly Drinker
6.575400E-01
Daily Drinker-vs-Occasional Drinker
2.246400E-01
Daily Drinker-vs-Social Drinker
1.520030E-01
Weekly Drinker-vs-Occasional Drinker
5.081400E-01
Weekly Drinker-vs-Social Drinker
3.722000E-01
Occasional Drinker-vs-Social Drinker
7.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.948000E-01
Normal-vs-Grade 2
8.997600E-01
Normal-vs-Grade 3
9.101800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.266600E-01
Grade 1-vs-Grade 3
7.938400E-01
Grade 1-vs-Grade 4
8.948000E-01
Grade 2-vs-Grade 3
8.195000E-01
Grade 2-vs-Grade 4
8.997600E-01
Grade 3-vs-Grade 4
9.101800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.143600E-02
Normal-vs-NonDiabetic
1.958750E-01
Diabetic-vs-NonDiabetic
1.179770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.354200E-01
Normal-vs-NoPancreatitis
1.363150E-01
Pancreatitis-vs-NoPancreatitis
2.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.481200E-01
Normal-vs-N1
2.470400E-01
N0-vs-N1
7.385600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.656200E-01
Normal-vs-TP53-NonMutant
4.343000E-01
TP53-Mutant-vs-TP53-NonMutant
5.873800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
